The use of artificial intelligence technology to predict lymph node spreadin men with clinically localized prostate carcinoma

Citation
Ed. Crawford et al., The use of artificial intelligence technology to predict lymph node spreadin men with clinically localized prostate carcinoma, CANCER, 88(9), 2000, pp. 2105-2109
Citations number
13
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
CANCER
ISSN journal
0008543X → ACNP
Volume
88
Issue
9
Year of publication
2000
Pages
2105 - 2109
Database
ISI
SICI code
0008-543X(20000501)88:9<2105:TUOAIT>2.0.ZU;2-J
Abstract
BACKGROUND. The current study assesses artificial intelligence methods to i dentify prostate carcinoma patients at low risk for lymph node spread. If p atients can be assigned accurately to a low risk group, unnecessary lymph n ode dissections can be avoided, thereby reducing morbidity and costs. METHODS. A rule-derivation technology for simple decision-tree analysis was trained and validated using patient data from a large database (4133 patie nts) to derive low risk cutoff, values for Gleason sum and prostate specifi c antigen (PSA) level. An empiric analysis was used to derive a low risk cu toff value for clinical TNM stage. These cutoff Values then were applied to 2 additional, smaller databases (227 and 330 patients, respectively) from separate institutions. RESULTS. The decision-tree protocol derived cutoff values of less than or e qual to 6 for Gleason sum and less than or equal to 10.6 ng/mL for PSA. The empiric analysis yielded a clinical TNM stage low risk cutoff value of les s than or equal to T2a. When these cutoff values were applied to the larger database, 44% of patients were classified as being at low risk for lymph n ode metastases (0.8% false-negative rate). When the same cutoff values were applied to the smaller databases, between II and 43% of patients were clas sified as low risk with a false-negative rate of between 0.0 and 0.7%. CONCLUSIONS, The results of the current study indicate that a population of prostate carcinoma patients at low risk for lymph node metastases can be i dentified accurately using a simple decision algorithm that considers preop erative PSA, Gleason sum, and clinical TNM stage. The risk of lymph node me tastases in these patients is less than or equal to 1%; therefore, pelvic l ymph node dissection may be avoided safely. The implications of these findi ngs in surgical and nonsurgical treatment are significant. (C) 2000 America n Cancer Society.